Asia Medical and Agricultural Laboratory and Research Center Future Growth
Future criteria checks 4/6
Asia Medical and Agricultural Laboratory and Research Center is forecast to grow earnings and revenue by 37.5% and 11.9% per annum respectively. EPS is expected to grow by 36.6% per annum. Return on equity is forecast to be 6.7% in 3 years.
Key information
37.5%
Earnings growth rate
36.6%
EPS growth rate
Professional Services earnings growth | 12.9% |
Revenue growth rate | 11.9% |
Future return on equity | 6.7% |
Analyst coverage | Low |
Last updated | 09 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 419 | 42 | N/A | N/A | 1 |
12/31/2025 | 375 | 34 | N/A | N/A | 1 |
12/31/2024 | 327 | 20 | N/A | N/A | 1 |
3/31/2024 | 305 | 15 | 8 | 57 | N/A |
12/31/2023 | 294 | 10 | -13 | 45 | N/A |
9/30/2023 | 279 | 7 | -4 | 48 | N/A |
6/30/2023 | 270 | 6 | 10 | 58 | N/A |
3/31/2023 | 266 | 9 | 26 | 50 | N/A |
12/31/2022 | 264 | 15 | 32 | 54 | N/A |
9/30/2022 | 272 | 27 | 34 | 58 | N/A |
6/30/2022 | 259 | 27 | 30 | 55 | N/A |
3/31/2022 | 252 | 25 | 40 | 65 | N/A |
12/31/2021 | 249 | 25 | 54 | 74 | N/A |
12/31/2020 | 220 | 28 | -116 | 50 | N/A |
12/31/2019 | 198 | 18 | -16 | 38 | N/A |
12/31/2018 | 165 | 4 | 1 | 17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMARC-F's forecast earnings growth (37.5% per year) is above the savings rate (1.9%).
Earnings vs Market: AMARC-F's earnings (37.5% per year) are forecast to grow faster than the TH market (14.8% per year).
High Growth Earnings: AMARC-F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMARC-F's revenue (11.9% per year) is forecast to grow faster than the TH market (6.6% per year).
High Growth Revenue: AMARC-F's revenue (11.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AMARC-F's Return on Equity is forecast to be low in 3 years time (6.7%).